AngioSoma, Inc. (OTCMKTS:SOAN) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

AngioSoma, Inc. (OTCMKTS:SOAN) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Story continues below

ITEM 5.02 Departure of Directors of Principal Officers; Election
of Directors; Appointment of Principal Officers

As of June 21, 2017, AngioSoma, Inc. (the Company) has appointed
two new independent directors, Robert W. Fryer and Bruce C.
Badeau. Mr. Fryer has also been appointed as the only member on
the Companys audit committee on same date.

Mr. Fryer earned a Bachelor of Business Administration degree
with a major in accounting from the University of Houston in May
2006. After that date, he served in several accounting firms and
independently as an accountant and auditor of numerous public and
private companies.

Mr. Badeau founded First Sovereign Equity Research in 1996 and
has served as its founding analyst continuously since that date.

ITEM 9.01 Financial Statements and Exhibits

Exhibit

14.1

Audit Committee Charter of the Company dated April 29, 2016



AngioSoma, Inc. Exhibit
EX-14.1 2 soan_ex14z1.htm AUDIT COMMITTEE CHARTER AUDIT COMMITTEE CHARTER   EXHIBIT 14.1 AUDIT COMMITTEE CHARTER The Audit Committee (Committee) shall consist of a minimum of one director. As determined by the Board of Directors in accordance with applicable requirements,…
To view the full exhibit click here

An ad to help with our costs